Epidemiology of post-infarction risk stratification strategies in a country with a low volume of revascularization procedures

European Heart Journal

Volumn 19, Issue 12, 1998, Pages 1784-1794

  Maggioni, Aldo Pietro ^a,b,g   Tavazzi, L ^d   Fabbri, G ^a   Lucci, D ^a   Santoro, E ^b   Canonico, A ^e   Galli, M ^f   Achilli, F ^c   Tognoni, G ^b  

^a ANMCO RESEARCH CENTER   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c SAN GERARDO HOSPITAL   (Italy)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^e VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^f IRCCS   (Italy)

^g GISSI Prognosis Coordinating Center   (Italy)

Author keywords

Epidemiology; Myocardial infarction; Prognosis; Risk stratification

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY BYPASS SURGERY; ELECTROCARDIOGRAPHY MONITORING; EXERCISE TEST; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; REGISTER; RISK ASSESSMENT; STATISTICAL MODEL; TRANSLUMINAL CORONARY ANGIOPLASTY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

AGED; COHORT STUDIES; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PHYSICIAN'S PRACTICE PATTERNS; PROGNOSIS; PROSPECTIVE STUDIES; REGISTRIES; RISK ASSESSMENT; TIME FACTORS;

EID: 0032402349     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1998.1236     Document Type: Article

References (41)

1. [1] Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343: 311-22.
2. [2] Weaver WD, Simes J, Betriu A et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction. JAMA 1997; 278: 2093-8.
3. [3] Goldberg RJ, Gore JM, Dalen JE. Current practice patterns in the management of acute myocardial infarction. Survey of the American College of Chest Physicians. Chest 1987; 92: 550-4.
4. [4] Bates DW, Miller E, Bernstein SJ, Hauptman PJ, Leape LL. Coronary angiography and angioplasty after acute myocardial infarction. Ann Intern Med 1997; 126: 539-50.
5. [5] Guadagnoli E, Hauptman PJ, Ayanian JZ, Pashos CL, McNeil BJ, Cleary PD. Variation in the use of cardiac procedures after acute myocardial infarction. N Engl J Med 1995; 333: 573-8.
6. [6] Pilote L, Miller DP, Califf RM, Rao JS, Weaver WD, Topol EJ. Determinants of the use of coronary angiography and revascularization after thrombolysis for acute myocardial infarction. N Engl J Med 1996; 335: 1198-205.
7. [7] Tu JV, Pashos CL, Naylor CD et al. Use of cardiac procedures and outcomes in elderly patients with myocardial infarction in the United States and Canada. N Engl J Med 1997; 336: 1500-5.
8. [8] Pashos CL, Newhouse JP, McNeil BJ. Temporal changes in the care and outcomes of elderly patients with acute myocardial infarction, 1987 through 1990. JAMA 1993; 270: 1832-6.
9. [9] Rouleau JL, Moye LA, Pfeffer MA et al. A comparison of management patterns after acute myocardial infarction in Canada and the United States. The SAVE Investigators. N Engl J Med 1993; 328: 779-84.
10. [10] Di Salvo TG, Paul SD, Lloyd-Jones D et al. Care of acute myocardial infarction by noninvasive and invasive cardiologist: procedure use, cost and outcome. J Am Coll Cardiol 1996; 27: 262-9.
11. [11] Every NR, Larson EB, Litwin PE et al. for the Myocardial Infarction Triage and Intervention Project Investigators. The association between on-site cardiac catheterization facilities and the use of coronary angiography after acute myocardial infarction. N Engl J Med 1993; 329: 546-51.
12. [12] Every NR, Parsons LS, Fihn SD et al. for the MITI Investigators. Long-term outcome in acute myocardial infarction patients admitted to hospitals with and without on-site cardiac catheterization facilities. Circulation 1997; 96: 1770-5.
13. [13] Schlant RC. Does the presence of an on-site cardiac catheterization facility in a hospital alter the long-term outcome of patients admitted with acute myocardial infarction? Circulation 1997; 96: 1711-2.
14. [14] Wennberg DE, Kellett MA, Dickens JD, Malenka DJ, Keilson LM, Keller RB. The association between local diagnostic testing intensity and invasive cardiac procedures. JAMA 1996; 275: 1161-4.
15. [15] Fleiss JI. Statistical methods for rates and proportions. New York, John Wiley & Sons, 1981: 218.
16. [16] Rovelli F, Tognoni G. Italy. The health service as a laboratory. Lancet 1996; 348: 169-70.
17. [17] Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; ii: 397-402.
18. [18] Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. GISSI-2 A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarction. Lancet 1990; 336: 65-71.
19. [19] Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. GISSI-3. Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994; 343: 1115-22.
20. [20] Peterson ED, Shaw LJ, Califf RM. Clinical Guideline: Part II. Risk stratification after myocardial infarction. Ann Intern Med 1997; 126: 561-82.
21. [21] Volpi A, De Vita C, Franzosi MG et al. Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 data base. The Ad hoc Working Group of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardio (GISSI)-2 Data Base. Circulation 1993; 88: 416-29.
22. [22] Villella A, Maggioni AP, Villella M et al., on behalf of the GISSI-2 Investigators. Prognostic significance of maximal exercise testing after myocardial infarction treated with thrombolytic agents: The GISSI-2 data-base. Lancet 1995; 346: 523-9.
23. [23] Yusuf S, Peduzzi P, Fisher LD et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomized trials by the coronary artery bypass graft surgery trialists collaboration. Lancet 1994; 344: 563-70.
24. [24] Varnausksas E, European Surgery Study Group. Twelve year follow-up of survival in the randomized European Coronary Surgery Study. N Engl J Med 1998; 319: 332-7.
25. [25] Maggioni AP, Zuanetti G, Franzosi MG et al. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results. Circulation 1993; 87: 312-22.
26. [26] Epstein AE, Hallstrom AP, Rogers WJ et al. Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction. The original design concept of the Cardiac Arrhythmia Suppression Trial (CAST). JAMA 1993; 270: 2451-5.
27. [27] American College of Physicians. Clinical Guideline: part I. Guidelines for risk stratification after myocardial infarction. Ann Intern Med 1997; 126: 556-60.
28. [28] Picano E, Pingitore A, Sicari R et al, on behalf of the Echo Persantine International Cooperative (EPIC) Study Group. Stress echocardiographic results predict risk of reinfarction early after uncomplicated acute myocardial infarction: large-scale multicenter study. J Am Coll Cardiol 1995; 26: 908-13.
29. [29] Carlos ME, Smart SC, Wynsen JC, Sagar KB. Dobutamine stress echocardiography for risk stratification after myocardial infarction. Circulation 1997; 95: 1402-10.
30. [30] Gibson RS, Watson DD, Craddock GB et al. Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography. Circulation 1983; 68: 321-36.
31. [31] Pirelli S, Inglese S, Suppa M, Corrada E, Campolo L. Dipyridamole-thallium 201 scintigraphy in the early postinfarction period. (Safety and accuracy in predicting the extent of coronary disease and future recurrence of angina in patients suffering from their first myocardial infarction). Eur Heart J 1988; 9: 1324-31.
32. [32] Mickelson JK, Blum CM, Gerane JM. Acute myocardial infarction: clinical characteristics, management and outcome in a metropolitan veterans affairs medical center teaching hospital. J Am Coll Cardiol 1997; 29: 915-25.
33. [33] ACC/AHA practice guidelines. ACC/AHA Guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1996; 28: 1328-428.
34. [34] Wright SM, Daley J, Peterson EO, Thibault GE. Outcomes of acute myocardial infarction in the Department of Veterans Affairs: does regionalization of health care work? Med Care 1997; 35: 128-41.
35. [35] McGovern PG, Herlitz J, Pankow JS, Karlsson T, Dellborg M, Shahar E, Luepker RV. Comparison of medical care and one-and 12-month mortality of hospitalized patients with acute myocardial infarction in Minneapolis-St. Paul, Minnesota, United States of America and Göteborg, Sweden. Am J Cardiol 1997; 80: 557-62.
36. [36] Tavazzi L, Volpi A for the GISSI Investigators. Remarks about postinfarction prognosis in light of the experience with the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI) Trial. Circulation 1997; 95: 1341-45.
37. [37] Madsen JK, Grande P, Saunamäki K et al., on behalf of the DANAMI Study Group. Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). Circulation 1997; 96: 748-55.
38. [38] Every NR, FIhn SD, Maynard C, Martin JS, Weaver WD for the MITI Investigators. Resource utilization in treatment of acute myocardial infarction: staff-model health maintenance organization versus fee-for-service hospitals. J Am Coll Cardiol 1995; 26: 401-6.
39. [39] Steingart RM, Packer M, Hamm P et al. for the Survival and Ventricular Enlargement Investigators. Sex differences in the management of coronary artery disease. N Engl J Med 1991; 325: 226-30.
40. [40] Payne N, Saul C. Variations in use of cardiology services in a health authority: comparison of coronary artery revascularisation rates with prevalence of angina and coronary mortality. BMJ 1997; 314: 257-61.
41. [41] Tudor Hart J. The inverse care law. Lancet 1971; i: 405-12.